Examining Clinical Trial Progress & Adaptive Strategies for Safer In Vivo Gene Editing
- Sharing early clinical data from ongoing patients dosing, accelerating confidence in therapeutic potential
- Implementing adaptive cohort designs and monitoring frameworks, improving trial flexibility and patient safety
- Aligning eligibility and dosing strategies with evolving biomarker insights, ensuring efficient global progression